Fitxa persona

Graduated in Medicine at University of Valencia in 2005, having completed the last two years of the degree at the University of Freiburg. Between 2005 and 2006 I did a research stay with a brain microdialysis project in mice at the Department of Child and Adolescent Psychiatry at the University of Freiburg. In 2007 I participated as a contracted researcher in a research project funded by the Carlos III Health Institute (ISCIII). Between 2008 and 2012 I did the neurology residency at Hospital la Fe, with a three-month training stay in the dementia department of the Massachusetts General Hospital and at the Martinos Center neuroimaging research center (Boston, USA). At the end of the residency, after a brief stint at the Hospital de Xátiva (Valencia), I joined the Research Group in Neuromuscular Pathology and Ataxias (GIPNMA) and the CIBERER, thanks to a competitive public contract of the IIS La Fe (2013 - 2017 ). Between 2018 and 2019 I continued my specialization in the diagnosis and treatment of rare neuromuscular diseases, particularly motor neuron diseases, thanks to a Rio Hortega contract from the ISCIII. In February 2019 I read the doctoral thesis on biomarkers and genetics in ELA. During these years I have participated in 17 research projects (in many of them as IP) and I collaborate with other researchers from the IISLaFe, the University of Murcia, the University of the Balearic Islands, the University of Girona, the IBV-CSIC, and of the CIPF. I have participated in numerous different clinical trials in dementia, neuropathies and SMA as a sub-investigator and in ALS as a principal investigator. I have published more than 40 articles in indexed journals and several book chapters. I have developed a software together with the UPV that is accepted and published in the Patent Bank of the Consellería de Economía Sostenible y Sectores Productivos. Since November 2019 I am an associate professor of neurology at the University of Valencia. Since January 2020 I work at Hospital la Fe, as coordinator of the motor neuron diseases unit, after being awarded with a contract of excellence Juan Rodés from the ISCIII.